BD Kiestra Urine Culture Application Powered by BD Synapsys Informatics Solution; Catalog (Ref): 444900;

FDA device recall Z-2585-2024 · posted 2024-08-14 · Open, Classified

Recall details

Recalling firm

Becton Dickinson & Co.

Reason for recall

There is a potential risk that the image colony count does not adequately reflect the actual plate colony count and may lead to inaccurate counts that would impact patient diagnosis and subsequent care.

Action taken

On July 9, 2024, "URGENT: Medical Device Product Correction" letters were sent to customers. Actions for Clinical Users: Users must review the plate images against the actual agar plate to verify the automated colony count results. Actions to be taken by customer: 1. Ensure the contents of this notification are read and understood. 2. Share and post this customer letter with the users of this application at your facility and forward to any customers to whom you may have distributed the product to ensure awareness. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form so that BD may acknowledge your receipt of this notification per FDA requirements. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fisher s Lane, Rockville, MD 20852-9787 Contact Information: If you require further assistance, please contact: BDRC42@bd.com or Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Complaints when prompted, Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com.

Root cause

Under Investigation by firm

Status

Open, Classified

Product code

KZB

Quantity affected

23 units

Distribution

US distribution to states of: CO, CT, IA, IL, KY, MD, MI, MN, NC, NJ, NY, OH, OK, SC, TN, TX and WA.

Date initiated

2024-07-09

Date posted

2024-08-14

Location

Sparks, MD